吉林男性早泻有什么治疗方法(吉林男生多长算正常) (今日更新中)

A Dutch woman is believed to be the first person in the world to die after contracting COVID-19 for a second time, according to multiple reports.Scientists report the 89-year-old woman suffered from a type of bone marrow cancer. She was admitted to the hospital earlier this year with severe cough and fever, and tested positive for the coronavirus. She left the hospital about a week later still feeling fatigue but other symptoms had gone.Two months later, she developed a fever, coughing and breathing difficulties, according to the Independent in the UK, while receiving chemotherapy treatment.The woman tested positive again for COVID-19 and doctors say she had no antibodies in her blood. She died two weeks later, according to CNN.Researchers believe the second infection was different and not prolonged symptoms of the first infection. They stated in their report the genetic makeup of the two virus samples from her infections are different. 958

A fifth person has died from his wounds as a result of Tuesday's Strasbourg Christmas market attack, the Paris prosecutor's office told CNN on Sunday.A gunman burst into the market in the evening hours Tuesday as crowds did their holiday shopping, killing three and wounding 13 more. The fourth victim, Antonio Megalizza, an Italian journalist who had been on life support since the attack, died on December 14, French authorities told CNN.CNN affiliate BFMTV reported that a 45-year-old man visiting from Thailand, an Afghan father of three who had been living in France for 15 years, and a man from Strasbourg also died in Tuesday's market attack.The authorities are calling the mass shooting a terrorist attack. Police killed the gunman Thursday night near the marketplace.The shooter, Cherif Chekatt, was known to prison officials for being radicalized and for his proselytizing behavior in detention in 2015, Paris prosecutor Rémy Heitz said, adding that he had been incarcerated multiple times in the past. French prosecutors said the suspect shouted the Arabic phrase "Allahu Akbar," meaning "God is greatest," at the time of the attack. 1152

A federal jury in New Jersey informed the judge Monday that it is deadlocked on all 12 counts in Sen. Bob Menendez's corruption case.Judge William Walls ordered the seven-woman, five-man jury home for the day to "clear their heads" and return Tuesday morning at 9:30 a.m. ET.It was a dramatic turn of events in a trial now entering its eleventh week. 358

A global research team of NASA’s Jet Propulsion Laboratory in Pasadena, California, using spectroscopes, have found hydrogen sulfide in the clouds or Uranus, NASA said on Tuesday. What is special about hydrogen sulfide is it is a common chemical on Earth humans like to avoid. Hydrogen sulfide is the same gas that rotten eggs emit. Yes, Uranus smells like rotten eggs. The presence of hydrogen sulfide has long been suspected on Uranus. NASA’s Voyager 2, which passed by the planet decades ago, detected the gas. But using Earth-based satellites, NASA has been able to confirm the presence of the gas. NASA said that finding hydrogen sulfide on Uranus is a striking difference compared to the other gas planets. Jupiter and Saturn have had ammonia detected in the clouds, but not hydrogen sulfide. “We’ve strongly suspected that hydrogen sulfide gas was influencing the millimeter and radio spectrum of Uranus for some time, but we were unable to attribute the absorption needed to identify it positively. Now, that part of the puzzle is falling into place as well,” Glenn Orton of NASA’s Jet Propulsion Laboratory said. If there is one bit of good news, scientists said: It would be impossible for the hydrogen sulfide to overtake humans. "Suffocation and exposure in the negative 200 degrees Celsius [392 degrees Fahrenheit] atmosphere made of mostly hydrogen, helium and methane would take its toll long before the smell," said lead author Patrick Irwin of the University of Oxford, U.K.    1582

A final analysis of a COVID-19 vaccine candidate produced by Pfizer and BioNTech shows that the drug is 95% effective in preventing the coronavirus, and the companies say they hope to apply for Emergency Use Authorization within "days," the company reported Wednesday.The announcement is an improvement from an initial analysis released by the company just over a week ago that showed the drug to be 90% effective. Those results were released when it had been confirmed that 94 participants in the trial who received a shot had contracted COVID-19, and only 10% of those participants who contracted the virus had actually received the vaccine. Updated information now shows that 170 people who participated in the trial have contracted COVID-19, which crosses the threshold for final analysis. Of those participants, 162 received a placebo shot. Of the 20,000 participants who received the vaccine, just one has developed a severe case of COVID-19. The other seven people who received the vaccine and caught the virus are only experiencing mild symptoms.Pfizer also added that the vaccine has proven to be 94% efficient in older people — a welcome sign, given that the virus tends to present more severe symptoms in elderly patients.Pfizer's trial included about 40,000 participants, half of which received the vaccine, and the other half which received the placebo. The vaccine requires two shots, which need to be taken 28 days apart.The company added that there have been no safety concerns with the vaccine. In a randomized survey of 8,000 participants, only 2% reported suffering severe fatigue, and only 4% reported suffering severe headaches. Those who say they suffered side effects only experienced them briefly after vaccination.Wednesday's announcement means Pfizer is on track to shatter records for vaccine development, a process that typically takes several years.Pfizer and BioNTech already have their vaccine candidate in production, meaning it will be ready for distribution as soon as the Food and Drug Administration grants Emergency Use Authorization.Pfizer's announcement comes days after an initial analysis of a Moderna-produced vaccine was also shown to be 95% effective. Several other companies also have a COVID-19 vaccine in the works, something that health officials say is important for logistics and safety. 2347

来源：资阳报